Gastrointestinal smooth muscle function (None)

Gastrointestinal smooth muscle function encompasses the coordinated contractile activity of muscle cells in the walls of the gastrointestinal tract. This function is regulated by neurotransmitter signaling (primarily via acetylcholine acting on muscarinic receptors M2 and M3), as well as specialized groups of interstitial cells (the interstitial cells of Cajal and PDGFRα+ cells) that act as pacemakers, conduct electrical slow waves, and modulate the muscle cell response to neural and chemical stimuli. The physiological process enables important motor patterns such as peristalsis, mixing, and sphincter control essential for proper digestion and transit throughout the GI tract[1][2][4][5]. Specific molecular targets include muscarinic acetylcholine receptors, voltage-dependent calcium channels, and other associated ion channels, which are modulated pharmacologically to treat various GI motility disorders. However, the overall function is the result of a network of interacting cells and molecular systems, rather than a single therapeutic target.

Other names

GI smooth muscle activityGI motilityGastrointestinal muscle contraction

Drugs targeting the regulation of gastrointestinal smooth muscle function act through various mechanisms: Muscarinic antagonists block acetylcholine from activating M2/M3 receptors, reducing contractions; Muscarinic agonists stimulate receptor-mediated contraction; Ion channel modulators alter membrane potential and Ca²⁺ influx, changing contractility; Prokinetics enhance neurotransmitter activity, stimulating contraction.